Plasma copeptin levels in patients with multiple sclerosis.
Antidiuretic hormone
Copeptin
Multiple sclerosis
Journal
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
14
04
2020
accepted:
15
04
2020
pubmed:
30
4
2020
medline:
19
3
2021
entrez:
30
4
2020
Statut:
ppublish
Résumé
We compared copeptin levels in relapsing-remitting multiple sclerosis (RRMS) patients with controls and investigated how plasma copeptin levels were changed with the disease period. Thirty patients with RRMS without a prior attack in the last twelve months, and 19 RRMS patients with a clinical acute attack and 30 healthy individuals were included into the study. Copeptin levels were significantly higher in all RRMS patient groups than healthy controls. Plasma copeptin levels were higher in patients in remission period compared with relapse period of 19 RRMS patients with an acute attack. We consider copeptin can be used as a potential biomarker for RRMS.
Identifiants
pubmed: 32345514
pii: S0967-5868(20)30348-9
doi: 10.1016/j.jocn.2020.04.095
pii:
doi:
Substances chimiques
Biomarkers
0
Glycopeptides
0
copeptins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
143-146Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.